Moby Strategic Execution and Portfolio Transformation. Management attributes the 2025 performance to a 'focus, execution, and growth ...

Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial ResultsFourth quarter revenue growth of 19% to $29.5 million2025 revenue growth ...

The "Exosome Diagnostic and Therapeutics Market – Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032" report ...

It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.

A Super Bowl ad used NFL tight ends to promote a finger-free prostate cancer screening. The ad, starring players like Rob Gronkowski, played heavily on humor to encourage men to get a PSA blood test.

LOS ANGELES--(BUSINESS WIRE)--MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of PROSTOX™ Standard, a new ...

Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. If you watched the Super Bowl, you ...

Move over Bad Bunny twerkers, the most unexpected part of the Super Bowl’s butt brigade might have been the advertisement using National Football League tight end players to promote finger-free ...

More than 15 abstracts showcase how the Veracyte Diagnostics Platform is advancing urologic cancer care with decisions guided by Decipher Prostate and Bladder tests SOUTH SAN FRANCISCO, ...

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today more than 15 abstracts featuring its urology portfolio will be presented at the 2026 ASCO Genitourinary Cancers ...